ロード中...
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors
Subacute cutaneous lupus erythematosus (SCLE) is an autoimmune disease that may be induced by proton pump inhibitors (PPIs) in at-risk populations. The US FDA does not recognize SCLE as an adverse event associated with PPIs. We queried the FDA Adverse Event Reporting System database, which contains...
保存先:
| 出版年: | Drugs Real World Outcomes |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4914530/ https://ncbi.nlm.nih.gov/pubmed/27398293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-016-0067-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|